Cargando…

Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis

BACKGROUND: This study was aimed at evaluating the correlation between Hepatocyte paraffin 1 (Hep par 1) and colorectal cancer. METHODS: To this end, 50 intestinal biopsies were analyzed including 10 colorectal polyps with low grade dysplasia, 10 with high grade dysplasia, 10 colorectal adenocarcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemolato, Sonia, Ravarino, Alberto, Fanni, Daniela, Coni, Pierpaolo, Di Felice, Eliana, Senes, Giancarlo, Faa, Gavino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139774/
https://www.ncbi.nlm.nih.gov/pubmed/27956971
http://dx.doi.org/10.4021/gr2009.10.1313
_version_ 1782472305086038016
author Nemolato, Sonia
Ravarino, Alberto
Fanni, Daniela
Coni, Pierpaolo
Di Felice, Eliana
Senes, Giancarlo
Faa, Gavino
author_facet Nemolato, Sonia
Ravarino, Alberto
Fanni, Daniela
Coni, Pierpaolo
Di Felice, Eliana
Senes, Giancarlo
Faa, Gavino
author_sort Nemolato, Sonia
collection PubMed
description BACKGROUND: This study was aimed at evaluating the correlation between Hepatocyte paraffin 1 (Hep par 1) and colorectal cancer. METHODS: To this end, 50 intestinal biopsies were analyzed including 10 colorectal polyps with low grade dysplasia, 10 with high grade dysplasia, 10 colorectal adenocarcinomas, 10 specimens of normal ileum and 10 of normal colon mucosa. Tissue sections were immunostained for Hep par 1 utilizing a commercial antibody. Normal colonic mucosa did not express Hep par 1. RESULTS: Immunoreactivity for Hep par 1 was detected in 20% of polyps with low grade dysplasia, 50% of polyps with high grade dysplasia and 60% of colorectal carcinomas. Hep par 1 was frequently detected in the deepest areas of adenocarcinomas mainly in infiltrating tumour cells. CONCLUSIONS: Our data show that Hep par 1 immunoreactivity in human colon carcinogenesis is correlated with progression from low grade to high grade dysplasia and adenocarcinoma. In clinical practice, our data show that caution should be taken in utilizing Hep par 1 as the sole tool in differentiating hepatocellular carcinoma from a liver metastasis of colon adenocarcinoma. Our data encourage further investigations into the potential role played by Hep par 1 in gastrointestinal carcinogenesis.
format Online
Article
Text
id pubmed-5139774
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-51397742016-12-12 Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis Nemolato, Sonia Ravarino, Alberto Fanni, Daniela Coni, Pierpaolo Di Felice, Eliana Senes, Giancarlo Faa, Gavino Gastroenterology Res Original Article BACKGROUND: This study was aimed at evaluating the correlation between Hepatocyte paraffin 1 (Hep par 1) and colorectal cancer. METHODS: To this end, 50 intestinal biopsies were analyzed including 10 colorectal polyps with low grade dysplasia, 10 with high grade dysplasia, 10 colorectal adenocarcinomas, 10 specimens of normal ileum and 10 of normal colon mucosa. Tissue sections were immunostained for Hep par 1 utilizing a commercial antibody. Normal colonic mucosa did not express Hep par 1. RESULTS: Immunoreactivity for Hep par 1 was detected in 20% of polyps with low grade dysplasia, 50% of polyps with high grade dysplasia and 60% of colorectal carcinomas. Hep par 1 was frequently detected in the deepest areas of adenocarcinomas mainly in infiltrating tumour cells. CONCLUSIONS: Our data show that Hep par 1 immunoreactivity in human colon carcinogenesis is correlated with progression from low grade to high grade dysplasia and adenocarcinoma. In clinical practice, our data show that caution should be taken in utilizing Hep par 1 as the sole tool in differentiating hepatocellular carcinoma from a liver metastasis of colon adenocarcinoma. Our data encourage further investigations into the potential role played by Hep par 1 in gastrointestinal carcinogenesis. Elmer Press 2009-10 2009-09-20 /pmc/articles/PMC5139774/ /pubmed/27956971 http://dx.doi.org/10.4021/gr2009.10.1313 Text en Copyright 2009, Nemolato et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Nemolato, Sonia
Ravarino, Alberto
Fanni, Daniela
Coni, Pierpaolo
Di Felice, Eliana
Senes, Giancarlo
Faa, Gavino
Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis
title Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis
title_full Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis
title_fullStr Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis
title_full_unstemmed Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis
title_short Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis
title_sort hepatocyte paraffin 1 immunoreactivity in early colon carcinogenesis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139774/
https://www.ncbi.nlm.nih.gov/pubmed/27956971
http://dx.doi.org/10.4021/gr2009.10.1313
work_keys_str_mv AT nemolatosonia hepatocyteparaffin1immunoreactivityinearlycoloncarcinogenesis
AT ravarinoalberto hepatocyteparaffin1immunoreactivityinearlycoloncarcinogenesis
AT fannidaniela hepatocyteparaffin1immunoreactivityinearlycoloncarcinogenesis
AT conipierpaolo hepatocyteparaffin1immunoreactivityinearlycoloncarcinogenesis
AT difeliceeliana hepatocyteparaffin1immunoreactivityinearlycoloncarcinogenesis
AT senesgiancarlo hepatocyteparaffin1immunoreactivityinearlycoloncarcinogenesis
AT faagavino hepatocyteparaffin1immunoreactivityinearlycoloncarcinogenesis